EN | DE
 info(at)helmholtz-hips.de +49681988063001
 Directions to Google
EN | DE
[Translate to Deutsch:]

Suche

Gesucht nach "drug". Zeige Ergebnisse 651 bis 660 von 672.

Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Publikation
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic A, Kress A, Carter-Timofte M, Holm E, van der Horst D, Kollmann C, Liu Z, Wang C, Hoang H, Kovalenko E, Chrysopoulou M, Twayana K, Ottosen R, Svenningsen E, Begnini F, Kiib A, Kromm F, Weiss H, Di Carlo D, Muscolini M, Higgins M, van der Heijden M, Arulanandam R, Bardoul A, Tong T, Ozsvar A, Hou W, Schack V, Holm C, Zheng Y, Ruzek M, Kalucka J, La Vega L, Elgaher W, Korshoej A, Lin R, Hiscott J, Poulsen T, O'Neill L, Roy D, Rinschen M, van Montfoort N, Diallo J, Farin H, Alain T, Olagnier D (2024)
Nat Commun, 15, 1, 10.1038/s41467-024-48422-x, 38750019

Citraconic acid and derivatives thereof for use as a medicament

Publikation
Frank Pessler, Fangfang Chen, Moritz Winterhoff, Konrad Büssow, Wulf Blankenfeldt, Anna Hirsch, Walid A. M. Elgaher (2024)
Patent, A61K31/122; A61K31/194; A61P31/16; C07C57/42; C07C61/20; C07C69/593;, US20240368065A1

Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold

Publikation
Khalifa H, ElHady A, Liu T, Elgaher W, Filhol-Cochet O, Cochet C, Abadi A, Hamed M, Abdel-Halim M, Engel M (2025)
European journal of medicinal chemistry, 282, 10.1016/j.ejmech.2024.117048, 39566243

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways

Publikation
Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic A, Kress A, Carter-Timofte M, Holm E, van der Horst D, Kollmann C, Liu Z, Wang C, Hoang H, Kovalenko E, Chrysopoulou M, Twayana K, Ottosen R, Svenningsen E, Begnini F, Kiib A, Kromm F, Weiss H, Di Carlo D, Muscolini M, Higgins M, van der Heijden M, Arulanandam R, Bardoul A, Tong T, Ozsvar A, Hou W, Schack V, Holm C, Zheng Y, Ruzek M, Kalucka J, La Vega L, Elgaher W, Korshoej A, Lin R, Hiscott J, Poulsen T, O'Neill L, Roy D, Rinschen M, van Montfoort N, Diallo J, Farin H, Alain T, Olagnier D (2024)
Nat Commun, 15, 1, 10.1038/s41467-024-55044-w, 39702301

Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections

Publikation
Wagner S, Sommer R, Hinsberger S, Lu C, Hartmann R, Empting M, Titz A (2016)
Journal of medicinal chemistry, 59, 13, 5929-69, 10.1021/acs.jmedchem.5b01698, 26804741

Targeting extracellular lectins of Pseudomonas aeruginosa with glycomimetic liposomes

Publikation
Metelkina O, Huck B, O'Connor J, Koch M, Manz A, Lehr C, Titz A (2022)
Journal of Materials Chemistry B, 10, 4, 537-548, 10.1039/d1tb02086b, 34985094

Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery

Publikation
Huck B, Thiyagarajan D, Bali A, Boese A, Besecke K, Hozsa C, Gieseler R, Furch M, Carvalho-Wodarz C, Waldow F, Schwudke D, Metelkina O, Titz A, Huwer H, Schwarzkopf K, Hoppstädter J, Kiemer A, Koch M, Loretz B, Lehr C (2022)
Advanced healthcare materials, 11, 11, 10.1002/adhm.202102117, 35112802

Advanced mutasynthesis studies on the natural α-pyrone antibiotic myxopyronin from Myxococcus fulvus

Publikation
Sahner J, Sucipto H, Wenzel S, Groh M, Hartmann R, Müller R (2015)
ChemBioChem, 16, 946-953, 10.1002/cbic.201402666, 25757034

Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing Congeners

Publikation
Frank N, Széles M, Akone S, Rasheed S, Hüttel S, Frewert S, Hamed M, Herrmann J, Schuler S, Hirsch A, Müller R (2021)
Molecules, 26, 16, 10.3390/molecules26164929

Protein‐Templated Hit Identification via an Ugi Four‐Component Reaction

Publikation
Mancini F, Unver M, Elgaher W, Jumde V, Alhayek A, Lukat P, Herrmann J, Witte M, Köck M, Blankenfeldt W, Müller R, Hirsch A (2020)
Chem. Eur. J., 10.1002/chem.202002250